MPLT: Gillis Jonathan sold $82K of stock
By AlphaYouPublished Form 4
GILLIS JONATHAN
Reporting filer
Gillis Jonathan reported selling 10,167 shares of MapLight Therapeutics, Inc. for about $82K ($8.08 a share on average). Form 4 filed Oct 16, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | GILLIS JONATHAN | 2026-10-15 | S | Sale | 10167 | 8.08 | 142,315 | 1 day | Filed terms
|
Voting Common Stock
- Owner
- GILLIS JONATHAN
- Date
- 2026-10-15
- Code
- S
- Action
- Sale
- Quantity
- 10167
- Price
- 8.08
- Following holdings
- 142,315
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Voting Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 10167
- id: F1
- transaction Price Per Share: 8.08
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 142315
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- GILLIS JONATHAN: CAO and Interim CFO.
- F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.